Healthcare Services

Increasing Obesity and Heart Disease Driving Growth in Type 1 Diabetes Market

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Type 1 Diabetes Market During The Forecast Period?

The market size for type 1 diabetes has seen rapid growth in recent years. Its value is projected to expand from $13.5 billion in 2025 to $15.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.1%. During previous periods, this growth was primarily fueled by the enhanced availability of insulin analogs, increasing diagnosis rates within pediatric groups, the establishment of more diabetes specialty care centers, greater awareness regarding autoimmune diabetes, and developments in glucose monitoring technologies.

The type 1 diabetes market is projected to experience swift expansion over the coming years. By 2030, this market is anticipated to reach $25.73 billion, demonstrating a compound annual growth rate (CAGR) of 13.9%. This expansion during the projection period stems from factors such as the increasing integration of closed-loop insulin delivery systems, increased funding for immunotherapy research, a heightened emphasis on treatments that modify the disease, the broadening of digital diabetes management platforms, and a growing call for patient-focused care approaches. Key developments expected within the forecast timeframe encompass the wider acceptance of continuous glucose monitoring systems, the increasing deployment of insulin pump technologies, a greater concentration on individualized insulin therapy, the broadening application of combination therapy strategies, and an intensified focus on early detection and effective disease management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12872&type=smp

What Key Factors Are Affecting The Type 1 Diabetes Market Demand?

The expanding female population is projected to fuel the advancement of the Turner syndrome market in the coming years. This demographic refers to the total count of females present in a specific geographic area or globally at any given time. The rise in the female population is primarily attributed to a longer female life expectancy, bolstered by improved healthcare systems and shifts in demographics. The Turner syndrome market offers support to the female population through growth hormone therapy, estrogen replacement, and comprehensive multidisciplinary care, all of which enhance physical development, reproductive health, and overall long-term well-being. For example, in March 2024, the U.S. Census Bureau, a U.S.-based federal government agency, reported that the United States had 0.168 billion females as of July 2022. Moreover, in 2023, Statistics Canada, a Canada-based national statistics agency, indicated that the number of females aged 15–64 grew to 0.01304 billion in 2023. Thus, the growing female population is a significant driver for the expansion of the Turner syndrome market.

How Is The Type 1 Diabetes Market Organized By Segment Classification?

The type 1 diabetes market covered in this report is segmented –

1) By Product Type: Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types

2) By Device: Insulin Pump, Insulin Pen, Blood Glucose Meter

3) By Application: Childrens, Adults

4) By End-User: Hospital, Research Institutes, Home Care

Subsegments:

1) By Rapid Acting Insulin Analogs: Insulin Lispro, Insulin Aspart, Insulin Glulisine

2) By Long-Acting Insulin Analogs: Insulin Detemir, Insulin Glargine, Insulin Degludec

3) By Premix Insulin Analogs: Premixed Insulin Lispro, Premixed Insulin Aspart, Premixed Insulin Glargine

4) By Other Product Types: Insulin Pumps, Continuous Glucose Monitoring Systems, Non-Insulin Medications, Combination Therapies

What Trends Are Influencing Changes In The Type 1 Diabetes Market?

Leading companies within the type 1 diabetes market are concentrating on developing advanced treatments, such as allogeneic islet cell transplantation, to provide functional beta-cell replacement and lessen insulin reliance in patients affected by type 1 diabetes. Allogeneic islet cell transplantation involves the infusion of pancreatic islet cells from a donor into the patient’s hepatic portal vein, with the goal of restoring the body’s own insulin production and decreasing the frequency of hypoglycemic episodes and insulin injections. For example, in June 2023, CellTrans Inc., a US-based biotechnology company, secured approval from the U.S. Food and Drug Administration (FDA) for Lantidra (donislecel), marking it as the first cellular therapy specifically for treating patients with type 1 diabetes. This clearance signifies a considerable achievement in regenerative medicine, offering a prospective long-term treatment choice for type 1 diabetes patients who contend with insulin dependence. Lantidra operates by replacing the insulin-producing cells obliterated by the immune system, thereby aiming to reinstate the body’s inherent capacity to regulate blood glucose levels.

Who Are The Industry Participants Involved In The Type 1 Diabetes Market?

Major companies operating in the type 1 diabetes market are Johnson and Johnson Limited, Merck and Co. Inc., Sanofi-Aventis LLC, Abbott Laboratories, Medtronic Plc, Eli Lilly and Co Ltd, Novo Nordisk A/S, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Adaptive Biotechnologies Corporation, Xeris Pharmaceuticals Inc, MannKind Corporation, Biocon Ltd, Virta Health Corp, Bigfoot Biomedical Inc, ViaCyte Inc, Beta Bionics Inc, Adocia SA, Senseonics Holdings Inc, Zealand Pharmaceuticals A/S, Provention Bio Inc

Get The Full Type 1 Diabetes Market Report:

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Which Region Dominates The Type 1 Diabetes Market By Market Share?

North America was the largest region in the type 1 diabetes market in 2025. The regions covered in the type 1 diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Type 1 Diabetes Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Browse Through More Reports Similar to the Global Type 1 Diabetes Market 2026, By The Business Research Company

Type 2 Diabetes Market Report 2026

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

Diabetes Care Devices Market

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Digital Diabetes Management Market Report

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795